EX-16.1 2 ex_686753.htm EXHIBIT 16.1 - AUDITOR'S SEC LETTER ex_686753.htm

Exhibit 16.1

 

 

b01.jpg

 

 

 

 

 

June 11, 2024

 

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

 

Commissioners:

 

We have read the statements made by Nuo Therapeutics, Inc. under Item 4.01 of its Form 8-K dated June 7, 2024. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of Nuo Therapeutics, Inc. contained therein.

 

Very truly yours,

 

b02.jpg

 

Marcum LLP

 

 

 

 

 

 

 

 

 

 

 

b03.jpg